-
Retrotope, Inc. is a drug
development company advancing the idea that
polyunsaturated fatty acids (PUFA)
drugs fortified with
heavy isotopes (reinforced...
- a
director of
Network ****ociates from 1997 to 1998, and
chairman of
Retrotope until 2020. In 2002, Saal was
chosen by the
United States Department of...
-
Renata (1993– )
Repligen (1981– )
Repros (subsidiary of Allergan, 1987– )
Retrotope (2006– )
Roche (1896– )
Rohto (1949– )
Romat (1992– )
RosePharma (2003–...
- (quinone 1) (NQO1)
enzyme to
increase the
biosynthesis of glutathione.
Retrotope is
advancing RT001. RT001 is a
deuterated synthetic homologue of ethyl...
- cells.
Deuterated ethyl ester of
linoleic acid (RT001),
developed by
Retrotope, is in a comp****ionate use
trial in
infantile neuroaxonal dystrophy and...
- conditions.
Concert was
acquired by Sun
Pharma in
March 2023. The
company Retrotope discovered and has been
developing a
deuterated fatty acid RT001 as a...
-
laboratory at
Boston University. He is also a co-founder and
Director of
Retrotope, a US-based
company using heavier isotopes of
carbon (13C) and hydrogen...
- JSTOR 3350258. PMID 7776947. "US FDA
Grants Orphan Drug
Designation for
Retrotope's RT001 in the
Treatment of
Phospholipase 2G6 (PLA2G6)-****ociated Neurodegeneration"...
- INC, as well as a
board member of the
American pharmaceutical company Retrotope,
specializing in biotechnology.
Artemev is
interested in
projects related...
- comparator-controlled
Phase I/II
clinical trial for Friedreich's ataxia,
sponsored by
Retrotope and Friedreich's
Ataxia Research Alliance, was
conducted to determine...
